Automate your services and focus on the important parts of your business. Create an automation flow once and sit back, as it runs in the background and helps you grow your service company with no extra work.
“I can assure you that Encharge is like having two full-time interns. This makes me focus 100% on analyzing the data and growing the marketing area much faster.”
Xavier Ribas Marketing Operations Analyst
1,800+ companies use Encharge to automate their marketing
Automate repetitive marketing operations
Create flows to automatically score leads. Assign tasks to sales reps in your favorite CRM like HubSpot or Salesforce. Notify team members with internal emails or Slack notifications to a specific person or a channel in your workspace, and more. Automating your whole service business has never been easier.
Deliver personalized experiences at scale
With powerful user segmentation, email personalization features, and native integrations with 50+ tools, you can design bespoke one-on-one experiences for your customers and never worry about scaling issues.
Send automated personalized messages
Never lose touch with your leads and your customers. Send relevant offers via email, Facebook Ads, or in-app messages.
Onboard new customers without lifting a finger
Send relevant onboarding emails to new customers, help them move in the right direction on their own.
Automate billing messaging and recover lost revenue
Automate messages and tasks when a new service trial starts or expires, send dunning emails, notify team members when you get a new customer, and more.
4.8/5 from 115 reviews
4.8/5 from 69 reviews
4.9/5 from 38 reviews
4.93/5 from 44 reviews
Meet your new marketing automation platform
Customer messaging tools don’t automate workflows outside your product and marketing automation tools are bad at behavior emails. Encharge is the best of both worlds — a marketing automation platform built specifically for startups and digital businesses.
“Encharge helped us visually redesign our onboarding flow resulting in a 10% increase in our trial activation rate."